Novel phosphorylcholine-containing protein of Pseudomonas aeruginosa chronic infection isolates interacts with airway epithelial cells

Journal of Infectious Diseases

Volumn 197, Issue 3, 2008, Pages 465-473

  Barbier, Mariette ^a   Oliver, Antonio ^a,b   Rao, Jayasimha ^c   Hanna, Sheri L ^c   Goldberg, Joanna B ^c   Albertí, Sebastián ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; PHOSPHORYLCHOLINE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BRONCHUS MUCOSA; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ANIMALS; BACTERIAL PROTEINS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED ICR; PHOSPHORYLCHOLINE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY MUCOSA; SPUTUM;

EID: 39349088513     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/525048     Document Type: Article

References (36)

1. Mosser JL, Tomasz A. Choline-containing teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity of lysis by an autolytic enzyme. J Biol Chem 1970; 245:287-98.
2. Weiser JN, Shchepetov M, Chong STH. Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae. Infect Immun 1997; 65:943-50.
3. Cundell DR, Gerard NP, Gerard C, Idanpaanheikkila I, Tuomanen EI. Streptococcuspneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995; 377:435-8.
4. Swords WE, Buscher BA, Li KVS, et al. Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol 2000; 37:13-27.
5. Rijneveld AW, Weijer S, Florquin S, et al. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J Infect Dis 2004; 189:711-6.
6. Weiser JN, Pan N, McGowan KL, Musher D, Martin A, Richards J. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J Exp Med 1998; 187:631-40.
7. Vincent JL. Nosocomial infections in adult intensive-care units. Lancet 2003; 361:2068-77.
8. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002; 15:194-222.
9. Evans SA, Turner SM, Bosch BJ, Hardy CC, Woodhead MA. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur Respir J 1996; 9:1601-4.
10. Mahenthiralingam E, Campbell ME, Speert DP. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 1994; 62:596-605.
11. Speert D, Campbell M, Puterman ML, et al. A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis. J Infect Dis 1994; 169:134-42.
12. Govan JRW, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996; 60:539-74.
13. Nguyen D, Singh PK. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc Natl Acad Sci USA 2006; 103:8305-6.
14. Oliver A, Canton R, Campo P, Baquero F, Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000; 288:1251-3.
15. Macia MD, Blanquer D, Togores B, Sauleda J, Perez JL, Oliver A. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother 2005; 49:3382-6.
16. Hogardt M, Hoboth C, Schmoldt S, Henke C, Bader L, Heesemann J. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis 2007; 195:70-80.
17. Weiser JN, Goldberg JB, Pan N, Wilson L, Virji M. The phosphorylcholine epitope undergoes phase variation on a 43-kilodalton protein in Pseudomonas aeruginosa and on pili of Neisseria meningitidis and Neisseria gonorrhoeae. Infect Immun 1998; 66:4263-7.
18. Gutiérrez O, Juan C, Pérez JL, Oliver A. Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients. Antimicrob Agents Chemother 2004; 48:3573-5.
19. Macia MD, Borrell N, Perez JL, Oliver A. Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion. Antimicrob Agents Chemother 2004; 48:2665-72.
20. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 1981; 256:1604-7.
21. Goldenberg HB, McCool TL, Weiser JN. Cross-reactivity of human immunoglobulin G2 recognizing phosphorylcholine and evidence for protection against major bacterial pathogens of the human respiratory tract. J Infect Dis 2004; 190:1254-63.
22. Hanna SL, Sherman NE, Kinter MT, Goldberg JB. Comparison of proteins expressed by Pseudomonas aeruginosa strains representing initial and chronic isolates from a cystic fibrosis patient: an analysis by 2-D gel electrophoresis and capillary column liquid chromatography-tandem mass spectrometry. Microbiology 2000; 146:2495-508.
23. Fleiszig SMJ, Evans DJ, Do N, Vallas V, Shin S, Mostov KE. Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity. Infect Immun 1997; 65:2861-7.
24. Kim JO, Weiser JN. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis 1998; 177:368-7.
25. Oliver A, Baquero F, Blazquez J. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol Microbiol 2002; 43:1641-50.
26. Granato D, Bergonzelli GE, Pridmore RD, Marvin L, Rouvet M, Corthesy-Theulaz IE. Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins. Infect Immun 2004; 72:2160-9.
27. Jacobson GR, Rosenbusch JP. Abundance and membrane association of elongation-factor Tu in Escherichia coli. Nature 1976; 261:23-6.
28. Dallo SF, Kannan TR, Blaylock MW, Baseman JB. Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae. Mol Microbiol 2002; 46:1041-51.
29. Harding SV, Sarkar-Tyson M, Smither SJ, et al. The identification of surface proteins of Burkholderia pseudomallei. Vaccine 2007; 25:2664-72.
30. Marques MAM, Chitale S, Brennan PJ, Pessolani MCV. Mapping and identification of the major cell wall-associated components of Mycobacterium leprae. Infect Immun 1998; 66:2625-31.
31. Weiser JN, Lindberg AA, Manning EJ, Hansen EJ, Moxon ER. Identification of a chromosomal locus for expression of lipopolysaccharide epitopes in Hemophilus-influenzae. Infect Immun 1989; 57:3045-52.
32. Zhang JR, Idanpaan-Heikkila I, Fischer W, Tuomanen EI. Pneumococcal licD2 gene is involved in phosphorylcholine metabolism. Mol Microbiol 1999; 31:1477-88.
33. Serino L, Virji M. Phosphorylcholine decoration of lipopolysaccharide differentiates commensal Neisseriae from pathogenic strains: identification of licA-type genes in commensal Neisseriae. Mol Microbiol 2000; 35:1550-9.
34. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2000; 2:1051-60.
35. Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Resp Crit Care Med 2005; 171:1209-13.
36. Hong WZ, Mason K, Jurcisek J, Novotny L, Bakaletz LO, Swords WE. Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media. Infect Immun 2007; 75:958-65.